Pulse Biosciences, Inc.
PLSE
Rang in aandelen
#4258
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aandeelprijs
$52.14
Marktkapitalisatie
$3.72B
Verandering (1 dag)
1.62%
Verandering (1 jaar)
202.26%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)
Categorie
Healthcare
Koersgeschiedenis voor Pulse Biosciences, Inc. (PLSE)
Hoogste slotkoers: $49.38 op 2026-10-01
Laagste slotkoers: $4.20 op 2016-05-01
Laagste slotkoers: $4.20 op 2016-05-01
Koersgeschiedenis van Pulse Biosciences, Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 91.54% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $437.06 | -17.07% |
US
|
|
| $197.48 | -45.39% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $197.59 | 33.60% |
US
|
|
| $69.39 | -9.34% |
CH
|
